When symptoms persist for more than three months after the initial COVID infection, this is generally referred to as long ...

(NASDAQ:DWTX) is advancing IMC-2 (valacyclovir + celecoxib) as a treatment for Long COVID. The drug is currently being ...

Scores of long COVID patients reached out to the Globe after a recent story on doctors who have uncovered new treatments.

More than 1 in 5 Americans likely suffer from long COVID, a new AI-assisted review has found. The analysis suggests that ...

Long COVID, also known as post-acute sequelae of SARS-CoV-2 infection (PASC), has become a concerning issue for many who suffer from lingering symptoms long after their initial infection has cleared.

Long COVID, a condition where symptoms persist for months after initial infection, affects many globally. It can contribute to debilitating conditions and complicate existing health issues. The ...

A new study has found the groups of people most likely to be diagnosed by a GP with Long COVID. But they aren’t necessarily ...

Summary: A new AI tool identified long COVID in 22.8% of patients, a much higher rate than previously diagnosed. By analyzing ...

New research by Harvard Medical School shows how an artificial intelligence (AI) algorithm created by Mass General Brigham ...

Most people with COVID-19 feel significantly better within a few days of first displaying any symptoms, but for some it can ...

New research indicates that people who contracted COVID-19 early in the pandemic faced a significantly elevated risk of heart ...

Some four years after the beginning of the Covid pandemic some 10,000 Long Covid sufferers are living on benefits because ...